1-3 of 3
Scott S. Tykodi
Close
Sort by
Journal Articles

Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

Hiroki Torikai, Andreas Reik, Frank Soldner, Edus H. Warren, Carrie Yuen, Yuanyue Zhou, Denise L. Crossland, Helen Huls, Nicholas Littman, Ziying Zhang, Scott S. Tykodi, Partow Kebriaei, Dean A. Lee, Jeffrey C. Miller, Edward J. Rebar, Michael C. Holmes, Rudolf Jaenisch, Richard E. Champlin, Philip D. Gregory, Laurence J. N. Cooper
Journal: Blood
Blood (2013) 122 (8): 1341–1349.
https://doi.org/10.1182/blood-2013-03-478255
Published: 2013
Includes: Supplemental data
Journal Articles

HLA and TCR Knockout by Zinc Finger Nucleases: Toward “off-the-Shelf” Allogeneic T-Cell Therapy for CD19 + Malignancies.

Hiroki Torikai, Andreas Reik, Carrie Yuen, Yuanyue Zhou, Denise Kellar, Helen Huls, Edus H. Warren, III, Scott S. Tykodi, Philip D. Gregory, Michael C. Holmes, Edward J. Rebar, Dean A. Lee, Richard E. Champlin, Chiara Bonini, Laurence Cooper
Journal: Blood
Blood (2010) 116 (21): 3766.
https://doi.org/10.1182/blood.V116.21.3766.3766
Published: 2010
Journal Articles

A Polymorphic Oncofetal Antigen Recognized by CD8 + CTL from Two Patients Experiencing Regression of Metastatic Renal Cell Carcinoma after Allogeneic HCT.

Edus H. Warren, MD, PhD, Jeffrey K. Mito, Scott S. Tykodi, MD, PhD, John A. Thompson, MD, Brenda M. Sandmaier, MD, Rainer Storb, MD, Stanley R. Riddell, MD, Benoît Van den Eynde, MD
Journal: Blood
Blood (2005) 106 (11): 3097.
https://doi.org/10.1182/blood.V106.11.3097.3097
Published: 2005